Week 3 Flashcards
What are the manifestations of Chediak-Higashi syndrome?
Giant lysosomal inclusions, ablinism, neuro defects, susceptibility to staph and strep.
What are the treatment options for gout?
1st line for acute: NSAIDs; 2nd line for acute: colchicine; Prophylaxis: uricosurics (for under-excretors) or xanthine oxidase inhibitors.
What is 7α hydroxylase?
It converts cholesterol to bile acids. Inhibition (by fibrates) reduces the conversion, resulting in excess cholesterol in the bile.
What are S/S of opiate withdrawal (4)?
Piloerection, dilated pupils, diaphoresis, fever.
What is the host defense against giardia?
Secretory IgA prevents adherence to duodenal and jejunal mucosa.
Describe the morphologic features of silicosis
Eggshell calcification of hilar nodes and birefringent particles surrounded by collagen.
Describe the morphologic features of beryllosis
Noncaseating epithelioid granulomas.
What is malignant hyperthermia? How does it present (5)?
It occurs due to hypersensitivity of skeletal muscles to inhaled anesthetics. Its due to an AD defect in the ryanodine receptors. Hyperthermia, tachycardia, rigidity, hyperkalemia, myoglobinuria.
How is malignant hyperthermia treated? What is its MOA?
Dantrolene (a muscle relaxant) It prevents Ca release from SR of skeletal muscle.
What is the HAART regimen? When is it initiated?
2 NRTIs + 1 NNRTI or 1 PI or 1 integrase inhibitor. Initiated w/ AIDS defining illness, CD4 <350, or high viral load.
Describe the inflammation of polyarteritis nodosa. What artery is always spared?
Segmental, transmural, necrotizing inflammation to small and medium-sized arteries. Fibrinoid necrosis is apparent. Pulmonary arteries are spared.
Subdural hematoma (blood vessel involved, location, clinical manifestation, CT)
Bridging cortical veins, between dura and arachnoid mater, gradual onset of HA and confusion, crescent-shaped hematoma.
What is lymphangiosarcoma? What condition is it associated with?
Malignancy of the endothelial lining of lymphatic channels. Assoc’d w/ prolonged lymphedema.
Name the serum marker: pancreatic cancer
CEA and CA19-9
Name the serum marker: ovarian cancer
CA-125
Name the serum marker: malignant epithelial tumor
CA-125
Name the serum marker: malignant melanoma
S-100
Name the serum marker: neural tumor
S-100
Name the serum marker: astrocytoma
S-100
Name the serum marker: metastasis to bone
Alk phos
Name the serum marker: neuroblastoma
Bombesin
Name the serum marker: lung cancer
Bombesin
Name the serum marker: gastric cancer
Bombesin
What are gene enhancers?
Stretches of DNA that alter transcription by binding transcription factors. They can be located anywhere upstream, downstream, or even within a gene.